Revolution Medicines (RVMD) Fair Value & DCF

RVMD$182.71-10.35 -5.36%
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$39.52BEnterprise value$42.83BRevenue (TTM)$197.56MMarket positionTop 25%

Score

49
Neutral
Value
40
Quality
21
Growth
85

Revolution Medicines, Inc. (RVMD) trades at $182.71 on $39.52B of equity value, with a trailing P/E of -21.83. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Revolution Medicines (RVMD) Fair Value & DCF

RVMD price $182.71 -10.35 -5.36%

Ticker
RVMD
Price
$182.71
Change
-10.35 -5.36%
Market cap
$39.52B
Dividend yield
0.00%
Beta
1.43
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
49
Value
40
Quality
21
Growth
85

Stocklytics score rationale: value 40, quality 21, growth 85.

AI Score 35. Revolution Medicines, Inc. has a high price of $199.7 with a market cap of $42.8 billion, but it is in the clinical development stage with significant negative margins, including a net profit margin of -9.5%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener